Orthofix Medical Inc. (OFIX)

Market Cap	486.29M
Revenue (ttm)	746.64M
Net Income (ttm)	-151.40M
Shares Out	37.41M
EPS (ttm)	-4.12
PE Ratio	n/a
Forward PE	20.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	439,619
Open	13.22
Previous Close	13.18
Day's Range	12.87 - 13.38
52-Week Range	9.57 - 21.60
Beta	1.05
Analysts	Hold
Price Target	15.50 (+19.23%)
Earnings Date	May 7, 2024

About OFIX

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,634
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX

Financial Performance

In 2023, OFIX's revenue was $746.64 million, an increase of 62.06% compared to the previous year's $460.71 million. Losses were -$151.40 million, 666.6% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for OFIX stock is "Hold." The 12-month stock price forecast is $15.5, which is an increase of 19.23% from the latest price.

Price Target

$15.5

(19.23% upside)

Analyst Consensus: Hold